Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Microenvironment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07564908
What this trial is testing

Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Neoplasms
Meng Qiu 64
Not applicableNot Yet RecruitingNCT06776198
What this trial is testing

Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

Who this might be right for
OsteosarcomaTranscriptomeTumor Microenvironment+1 more
Peking University People's Hospital 100
Not applicableStudy completedNCT03267641
What this trial is testing

Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 86
Not applicableLooking for participantsNCT04363983
What this trial is testing

Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms

Who this might be right for
Gastrointestinal Neoplasms
Assistance Publique - Hôpitaux de Paris 6,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592653
What this trial is testing

Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)

Who this might be right for
Advanced Solid Tumor
Mural Oncology, Inc 78
Testing effectiveness (Phase 2)Looking for participantsNCT07205731
What this trial is testing

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
University Hospital, Clermont-Ferrand 95
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Not applicableStudy completedNCT07631611
What this trial is testing

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

Who this might be right for
Solid TumorsMetastatic Cancer to LiverMetastatic Cancer to the Bone+5 more
Wenlong Zhong, MD 938
Not applicableLooking for participantsNCT07669493
What this trial is testing

Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study

Who this might be right for
MACE, Arrhythmia, Pericardial Effusion and Survival
Hebei Medical University Fourth Hospital 150
Not applicableUnknownNCT03846856
What this trial is testing

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

Who this might be right for
Ovarian Cancer
Hillel Yaffe Medical Center 40
Not applicableEnded earlyNCT04875871
What this trial is testing

Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors

Who this might be right for
Cancer
EBG MedAustron GmbH 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05114421
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients

Who this might be right for
High Grade Fallopian Tube Serous AdenocarcinomaHigh Grade Ovarian Serous AdenocarcinomaPeritoneal High Grade Serous Adenocarcinoma+3 more
M.D. Anderson Cancer Center 30
Not applicableNot Yet RecruitingNCT07584317
What this trial is testing

AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)

Who this might be right for
Hepatocellular Carcinoma
Gao-jun Teng 1,170
Not applicableNot Yet RecruitingNCT07198802
What this trial is testing

Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 600
Not applicableLooking for participantsNCT07427186
What this trial is testing

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Who this might be right for
Solid Cancers
Institut Claudius Regaud 600
Testing effectiveness (Phase 2)Ended earlyNCT02569957
What this trial is testing

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Malignant Ovarian Endometrioid TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube Carcinoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 1
Not applicableLooking for participantsNCT06084195
What this trial is testing

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

Who this might be right for
High Grade Serous Ovarian Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 120
Early research (Phase 1)Ended earlyNCT02559492
What this trial is testing

Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 142
Not applicableLooking for participantsNCT06536998
What this trial is testing

Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）

Who this might be right for
Liver Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Very early researchLooking for participantsNCT07065552
What this trial is testing

Tirzepatide in Obesity-Driven Endometrial Cancer

Who this might be right for
Endometrial CancerObesity
UNC Lineberger Comprehensive Cancer Center 20
Next Page